Neptune Resources, LLC

FDA Issues Class I Recall for Neptune's Fix Tianeptine Products: Critical Regulatory Risk for Unapproved Substances

Neptune Resources, LLC faces an FDA Class I recall (D-0335-2024) for its Neptune's Fix Tianeptine Tablets Extended Relief, due to marketing an unapproved drug. This event underscores severe regulatory risks for firms distributing non-FDA-approved substances, demanding immediate review of product portfolios and stringent compliance protocols to mitigate significant commercial and legal exposure.